Stories by Rafael Amado

Rafael Amado is a former president of research and development at Adaptimmune. He is currently chief medical officer of Allogene Therapeutics.

The Next Wave of Immuno-Oncology

A cutting-edge therapy currently used for blood cancers is now being adapted to fight solid tumors

Rafael Amado, Elliot Norry